Vaccines comprising innovative adjuvants are rapidly reaching advanced translational
stages, such as the authorized nanotechnology adjuvants in mRNA vaccines against COVID …

Nanomaterials (NMs) have increasingly been used for the diagnosis and treatment of head
and neck cancers (HNCs) over the past decade. HNCs can easily infiltrate surrounding …

Nanoparticle (NP)-based mRNA cancer vaccines hold great promise to realize personalized
cancer treatments. To advance this technology requires delivery formulations for efficient …

Cancer vaccination is an effective way to prevent or cure cancers by inducing strong cellular
and humoral immunity with the aid of delivery carriers or adjuvants. Increasing new delivery …

Persistent infection with high-risk human papillomaviruses (HPVs), such as HPV-16 and
HPV-18, can induce cervical cancer in humans. The disease carries high morbidity and …

Nanomedicines can integrate multiple functionalities to improve the efficacy of disease
treatment with reduced off-target toxicity. However, challenges such as tedious synthesis …

Cancer vaccines, which activate the immune system against a target antigen, are attractive
for prostate cancer, where multiple upregulated protein targets are identified. However …

Cancer nanovaccines represent a promising frontier in cancer immunotherapy, utilizing
nanotechnology to augment traditional vaccine efficacy. This review comprehensively …

Peptide-based vaccines, which form one of the most potent vaccine platforms, offer
exclusive advantages over classical vaccines that use whole organisms or proteins …

Cancer immunotherapy, a promising and widely applied mode of oncotherapy, makes use of
immune stimulants and modulators to overcome the immune dysregulation present in …